21
Enrolling Prevention Studies Galileo - PI: Paul Sorajja, MD RCT comparing Rivaroxaban + ASA vs clopidogrel + ASA in post TAVR patients Objective: To compare death or first thromboembolic events Subjects: High Risk patients receiving TAVR for on l Contact: Stephanie Ebnet, phone: 612.863.6286 DalGenE - PI: Thomas Knickelbine, MD RCT comparing Dalctrapib (CETP inhibitor - raises HDL) vs Placebo Objective: Compare time to MACE Subjects post ACS with ADCY9 AA genotype Contact: Christine Majeski, phone: 612.863.3546, pager: 612.654.6444 CASCADE Registry- PI: Thomas Knickelbine, MD National Registry for patients with familial hypercholesterolemia Objective: Promote awareness of FH prevalence, risk factors and optimal management Subjects: Patients diagnosed Familial hypercholesterolemia (FH) Contact: Christine Majeski, phone: 612.863.3546, pager: 612.654.6444

Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

Enrolling Prevention Studies‣Galileo - PI: Paul Sorajja, MD

‣ RCT comparing Rivaroxaban + ASA vs clopidogrel + ASA in post TAVR patients‣ Objective: To compare death or first thromboembolic events‣ Subjects: High Risk patients receiving TAVR for on lContact: Stephanie Ebnet, phone: 612.863.6286

‣DalGenE - PI: Thomas Knickelbine, MD ‣ RCT comparing Dalctrapib (CETP inhibitor - raises HDL) vs Placebo‣ Objective: Compare time to MACE‣ Subjects post ACS with ADCY9 AA genotypeContact: Christine Majeski, phone: 612.863.3546, pager: 612.654.6444

‣CASCADE Registry- PI: Thomas Knickelbine, MD ‣ National Registry for patients with familial hypercholesterolemia‣ Objective: Promote awareness of FH prevalence, risk factors and optimal management ‣ Subjects: Patients diagnosed Familial hypercholesterolemia (FH)Contact: Christine Majeski, phone: 612.863.3546, pager: 612.654.6444

Page 2: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

C A R D I O L O G Y G R A N D R O U N D S Title: Reimagining secondary prevention and cardiac rehabilitation using telehealth

Speaker: Adelanwa Adesanya, MS Co-founder Moving Analytics, Inc

. Date: Monday, January 30, 2017 Time: 7:00 – 8:00 AM

Location: ANW Education Building, Watson Room

OBJECTIVES At the completion of this activity, the participants should be able to:

1. Describe the importance of secondary prevention programs like cardiac rehabilitation and the factors behind their low utilization.

2. Discuss the role, benefits and key evidence supporting telehealth in secondary prevention. 3. Prepare a business plan including reimbursement pathways, cost, and return on investment for

telehealth in secondary prevention of heart disease.

ACCREDITATION Physician Allina Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Allina Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse This activity has been designed to meet the Minnesota Board of Nursing continuing education requirements for 1.2 hours of credit. However, the nurse is responsible for determining whether this activity meets the requirements for acceptable continuing education.

DISCLOSURE STATEMENTS Moderator(s)/Speaker(s) Mr. Adesanya has disclosed the following relationship; Stock Shareholder: Moving Analytics, Inc.

Planning Committee Dr. Alex Campbell, Dr. Kevin Harris, Rebecca Lindberg, Dr. Michael Miedema, Dr. JoEllyn Carol Moore, Dr. Scott Sharkey, and Jolene Bell Makowesky have declared that they do not have any conflicts of interest associated with the planning of this activity. Dr. David Hurrell declares the following relationship –Boston Scientific: Chair, Clinical Events Committee.

PLEASE SAVE A COPY OF THIS FLIER AS YOUR CERTIFICATE OF ATTENDANCE

Signature: __________________________________________________________________________ My signature verifies that I have attended the above stated number of hours of the CME activity.

Allina Health - Learning & Development - 2925 Chicago Ave - MR 10701 - Minneapolis MN 55407

Page 3: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

1

Reimagining cardiac rehabilitation using telehealth

Ade Adesanya, MSCo-Founder, Moving Analytics Inc.Cardiology Grand RoundsMinneapolis Heart Institute Foundation Monday, January 30, 2017

2

C r i s i s

Page 4: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

3

Harsh Vathsangam, PhDCo-Founder & CEO

Nine years experience in big-data and software development for chronic disease management

Ade Adesanya, MSCo-Founder

Led the implementation of remote chronic care management programs at leading hospitals

including Mayo, NYU, VA

Nancy Houston Miller, RN, FAHA, FAACVPR, FPCNAChief Clinical Officer

Fmr. Assoc. Director of Stanford Cardiac Rehab, co-inventor MULTIFIT, Past AHA board member and co-founder of PCNA

Robert DeBusk, MD, FAHAMedical Affairs

Fmr. Director of Stanford Cardiac Rehab, Co-Inventor MULTIFIT, Past AHA board

member

Winner, 2015 Innovation award by

6

NEED FOR SECONDARY PREVENTION

Page 5: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

7

Meet Joe

Age: 65Medical History• Recent MI• EF:30• History of Smoking• Diabetic

8

R e f e r r a l t o C a r d i a c R e h a b

Class 1 indication for MI, PCI, CABG,

chronic stable angina, & chronic

systolic heart failure.

AHA/ACC Guidelines

Page 6: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

9

B E N E F I T S O F C R

13-24% Reduction in Mortality

31% decrease in hospitalizations

Increase in physical function & QOL

Ades, Philip et al "Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative." Mayo Clinic Proceedings (2016): n. pag. Web.

Medicare patients hospitalized for

CABG or MI 2000-07 2007-12

Referral to CR 56% a 73% - 81% c

Participation in CR <20% b <20% d

References

a Brown, JACC 2009b Suaya, JACC 2007

c Beatty, JACC 2014d Beatty, Circ QCOR

2015

Referral to and Participation in Cardiac Rehab

Page 7: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

11

I M P L I C AT I O N S

Patients

Health Systems

Society

12

7 0 % U T I L I Z AT I O N B Y 2 0 2 2

70% CR participation by 2020

Page 8: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

13

EVIDENCE FOR HOME CR

14

C O M P O N E N T S O F H O M E C R

Exercise coaching Risk factor management

Medication Adherence

Psychosocial Support Education

Page 9: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

Home‐ and center‐based forms of cardiac rehabilitation seem to be equally effective for improving clinical and health‐related quality of life outcomes. This finding supports the continued expansion of home‐based programs.

Cochrane Database of Systematic Reviews 2015, Issue 8 www.cochranelibrary.com

• N= 1289

• N= 598

• N= 194

• N= 212

• N= 686

• N= 1748

• N= 1192

Congestive Heart Failure

Hypertrophic Cardiomyopathy

Pulmonary Hypertension

Aortic Stenosis

Age 75 or Older

Women

Peak V02 < 14 ml/kg/min

5060 exercise studies in 4250 high risk patients, including:

Circulation 2012;126:2465‐2472

Adverse events in 1/625 studies (no 

deaths)

Page 10: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

17

L I M I TAT I O N S O F H O M E C R

Objective monitoring Technology

Quality Control Financial Incentive

18

ROLE OF TELEHEALTH IN CR

Page 11: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

Heart, 2014

• RCT of 120 post‐MI patients• Smartphone‐based home CR (vs. center‐based CR)• Greater uptake, adherence, and completion of CR• Similar improvements in exercise capacity

20

P A T I E N T C E N T E R E D C R C H E C K L I S T

Evidence Based Convenient & Affordable

Cost effective to implement High Quality

Page 12: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

21

R O B E R T D E B U S K , M DFAHA

LY N D A M U R D O C KN AN C Y H O U S T O N M I L L E R , R NFAHA, FAACVPR,

FPCNA

22

C L I N I C A L E V I D E N C E

Our solutions were developed in collaboration with Stanford Medicine, validated through

multiple clinical trials and has improved the lives of over 70,000 patients in the Kaiser

Permanente System.

11%I M P R O V E M E N T I N

F U N C T I O N AL C APAC I T Y

70%S M O K I N G

C E S S AT I O N R AT E

19%R E D U C T I O N I N L D L

C H O L E S T E R O L

40%C AD

R E AD M I S S I O N SR E D U C T I O N

“Home-based cardiac rehabilitation and Lifestyle Modification: The MULTIFIT Model,” Miller et al.

Page 13: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

A powerful and flexible

care management platform

Library of evidence-based

content for CAD, CHF, HTN, DM

and Smoking Cessation

Developed at Stanford University, backed by multiple clinical trials

With a suite of mobile apps to coach patients at home

Implementation, training and

technical support services

To make your program a success

25

PAT I E N T C E N T E R E D M O D E L S

Hybrid

• Combination of home & center based CR

Population

• Home CR with remote coaching

Engagement

• Self management program with remote monitoring

Page 14: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

26

P R O D U C T E N G A G E M E N T

60%E N R O L L M E N T

R AT E S

80%C O M P L E T I O N

R AT E S

118M I N U T E S

E X E R C I S E D / W K / PAT I E N T

Age Range: 30 – 90 Average and Median: 57

90%S TAF F AN D PAT I E N T

S AT I S FAC T I O N

27

ROI FOR CR

Page 15: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

28

M E D I C A R E / F F S R E I M B U R S E M E N T

TRADITIONAL HYBRID POPULATION

# of sessions 36 12 2

Reimbursement $3,600 $1,200 $200

Staffing 1:4 1:400 1:300

$100/session with CPT Code:

93797(8)

29

T E L E - H E A LT H R E I M B U R S E M E N T

“Telemedicine parity laws require private payers in that state to reimburse the same way they would for

in-person medical treatment.”

Page 16: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

30

M I N N E S O TA PA R I T Y L AW

Meet with your insurance provider to agree to• Accept the cardiac rehabilitation CPT codes as a telemedicine

service• Method of telecommunication for telemedicine • Evidence, safety or efficacy of delivering a service• Documentation or billing practices to protect against fraud

Source: MN Senate File 1458 (2015). MN Statute Sec. 62A.672.

31

VA L U E - B A S E D R E I M B U R S E M E N T

CMS Bundled PaymentsHospital responsible for 90 day readmissions

Page 17: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

32

F INAL THOUGHTS

33

Meet Joe

Age: 65Medical History• Recent MI• EF:30• History of Smoking• Diabetic

Page 18: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

35

Page 19: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

37

Page 20: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

39

B E N E F I T S

Increased patient satisfaction and outcomes

Enhanced patient-provider relationship

Lower readmissionsAdditional revenues from more patient sessions

Increased attendance and graduation rates

Improved insight into patient behaviors to personalize care

Page 21: Enrolling Prevention Studies · MHIF CV Grand Rounds –Jan. 30, 2017 21 ROBERT DEBUSK, FAHAMD NANCY HOUSTON MILLER, LYNDA MURDOCK FAHA, FAACVPR, RN FPCNA 22 CLINICAL EVIDENCE Our

MHIF CV Grand Rounds – Jan. 30, 2017

40

Ade Adesanya

[email protected]

832-851-4133

www.movinganalytics.com

41

Q U E S T I O N S & F E E D B A C K